StonvexLoading…
StonvexStonvexStonvexCore line items from WAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $67.20M | $135.80M | $71.00M | $46.50M |
Operating Income | $231.30M | $1.21B | $851.50M | $537.70M |
Net Income | $182.10M | $969.00M | $682.90M | $429.50M |
EPS (Diluted) | $1.65 | $8.73 | $6.14 | $3.86 |
Total Assets | $98.85B | $92.77B | $90.97B | $86.72B |
Total Liabilities | $90.94B | $84.83B | $83.28B | $79.32B |
Cash & Equivalents | $8.55B | $3.60B | $5.76B | $2.77B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 108.70M | 109.50M | 109.60M | 109.60M |